Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: HDT BIO CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2022-07-01 to 2025-06-30
Current total value of award: $1499422
Description: ADAPTABLE RNA-BASED ANTIBODY PLATFORM FOR PROTECTION AGAINST CONTEMPORARY/EMERGING HUMAN ENTEROVIRUSES